AirSculpt Technologies (AIRS) Competitors $7.26 -0.05 (-0.63%) As of 12:57 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock AIRS vs. VRDN, PACS, GRAL, TDOC, OMDA, AHCO, NAKA, FTRE, PNTG, and CDNAShould you be buying AirSculpt Technologies stock or one of its competitors? The main competitors of AirSculpt Technologies include Viridian Therapeutics (VRDN), PACS Group (PACS), GRAIL (GRAL), Teladoc Health (TDOC), Omada Health (OMDA), AdaptHealth (AHCO), KindlyMD (NAKA), Fortrea (FTRE), The Pennant Group (PNTG), and CareDx (CDNA). These companies are all part of the "healthcare" industry. AirSculpt Technologies vs. Its Competitors Viridian Therapeutics PACS Group GRAIL Teladoc Health Omada Health AdaptHealth KindlyMD Fortrea The Pennant Group CareDx AirSculpt Technologies (NASDAQ:AIRS) and Viridian Therapeutics (NASDAQ:VRDN) are both small-cap healthcare companies, but which is the superior stock? We will compare the two businesses based on the strength of their institutional ownership, earnings, valuation, analyst recommendations, media sentiment, dividends, profitability and risk. Which has more risk and volatility, AIRS or VRDN? AirSculpt Technologies has a beta of 2.49, indicating that its stock price is 149% more volatile than the S&P 500. Comparatively, Viridian Therapeutics has a beta of 0.53, indicating that its stock price is 47% less volatile than the S&P 500. Is AIRS or VRDN more profitable? AirSculpt Technologies has a net margin of -8.79% compared to Viridian Therapeutics' net margin of -112,806.88%. AirSculpt Technologies' return on equity of -15.63% beat Viridian Therapeutics' return on equity.Company Net Margins Return on Equity Return on Assets AirSculpt Technologies-8.79% -15.63% -6.30% Viridian Therapeutics -112,806.88%-78.95%-49.91% Do insiders & institutionals have more ownership in AIRS or VRDN? 91.5% of AirSculpt Technologies shares are held by institutional investors. 76.6% of AirSculpt Technologies shares are held by company insiders. Comparatively, 1.6% of Viridian Therapeutics shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth. Does the media refer more to AIRS or VRDN? In the previous week, Viridian Therapeutics had 3 more articles in the media than AirSculpt Technologies. MarketBeat recorded 4 mentions for Viridian Therapeutics and 1 mentions for AirSculpt Technologies. Viridian Therapeutics' average media sentiment score of 1.08 beat AirSculpt Technologies' score of 0.64 indicating that Viridian Therapeutics is being referred to more favorably in the news media. Company Overall Sentiment AirSculpt Technologies Positive Viridian Therapeutics Positive Which has preferable earnings and valuation, AIRS or VRDN? AirSculpt Technologies has higher revenue and earnings than Viridian Therapeutics. AirSculpt Technologies is trading at a lower price-to-earnings ratio than Viridian Therapeutics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAirSculpt Technologies$180.35M2.51-$8.25M-$0.25-29.06Viridian Therapeutics$300K5,365.72-$269.95M-$3.83-5.15 Do analysts prefer AIRS or VRDN? AirSculpt Technologies currently has a consensus price target of $3.75, suggesting a potential downside of 48.38%. Viridian Therapeutics has a consensus price target of $34.88, suggesting a potential upside of 76.94%. Given Viridian Therapeutics' stronger consensus rating and higher possible upside, analysts clearly believe Viridian Therapeutics is more favorable than AirSculpt Technologies.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score AirSculpt Technologies 0 Sell rating(s) 3 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00Viridian Therapeutics 0 Sell rating(s) 1 Hold rating(s) 8 Buy rating(s) 0 Strong Buy rating(s) 2.89 SummaryAirSculpt Technologies beats Viridian Therapeutics on 9 of the 16 factors compared between the two stocks. Get AirSculpt Technologies News Delivered to You Automatically Sign up to receive the latest news and ratings for AIRS and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding AIRS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart AIRS vs. The Competition Export to ExcelMetricAirSculpt TechnologiesTechnology Services IndustryBusiness SectorNASDAQ ExchangeMarket Cap$454.56M$3.08B$27.65B$10.31BDividend YieldN/A1.59%2.75%4.64%P/E Ratio-29.1224.8127.0625.99Price / Sales2.5157.87739.98124.87Price / Cash43.4147.7727.8861.24Price / Book5.307.707.816.28Net Income-$8.25M$34.86M$200.69M$270.94M7 Day Performance10.90%-1.88%-1.09%-0.21%1 Month Performance14.21%11.96%9.78%5.68%1 Year Performance29.95%87.05%63.26%27.59% AirSculpt Technologies Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)AIRSAirSculpt Technologies0.4811 of 5 stars$7.26-0.6%$3.75-48.4%+34.9%$454.56M$180.35M-29.12240News CoverageVRDNViridian Therapeutics1.7639 of 5 stars$18.01-4.6%$37.78+109.8%-10.8%$1.54B$300K-4.7050PACSPACS Group2.8708 of 5 stars$10.41+6.8%$31.00+197.8%-68.1%$1.49B$3.56B0.0032,433Upcoming EarningsHigh Trading VolumeGRALGRAIL0.4737 of 5 stars$39.33+3.4%$31.50-19.9%+269.5%$1.37B$125.60M-3.001,360Gap UpTDOCTeladoc Health2.6332 of 5 stars$7.67-0.2%$9.80+27.8%-6.1%$1.36B$2.54B-6.445,500Options VolumeOMDAOmada HealthN/A$22.14+0.8%$24.50+10.7%N/A$1.26BN/A0.00849AHCOAdaptHealth3.6421 of 5 stars$9.11-1.9%$13.40+47.1%-14.3%$1.26B$3.24B16.8710,500NAKAKindlyMD2.4847 of 5 stars$1.24-55.4%$8.00+545.2%N/A$1.05B$2.72M-1.44N/APositive NewsHigh Trading VolumeFTREFortrea3.7425 of 5 stars$10.20+1.0%$11.50+12.7%-54.2%$917.08M$2.73B-0.9015,500Positive NewsPNTGThe Pennant Group4.4518 of 5 stars$25.20-1.5%$34.40+36.5%-31.2%$884.10M$798.92M32.317,000CDNACareDx4.0746 of 5 stars$14.02+3.6%$25.50+81.9%-48.5%$720.16M$333.79M13.75740Analyst Forecast Related Companies and Tools Related Companies VRDN Alternatives PACS Alternatives GRAL Alternatives TDOC Alternatives OMDA Alternatives AHCO Alternatives NAKA Alternatives FTRE Alternatives PNTG Alternatives CDNA Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:AIRS) was last updated on 9/26/2025 by MarketBeat.com Staff From Our PartnersWhy More Investors Are Using Family Trusts to Protect Their WealthFor many investors, a family trust can be an essential tool for protecting assets, avoiding probate, and ensur...SmartAsset | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredPrepare for the “Mar-a-Lago Accord” Money ShockWhy Are Wall Street Insiders Moving Their Money to This ONE Asset? Something far more consequential for you...Stansberry Research | SponsoredWhat The Silver Boom Could Mean For You…AI, electric vehicles, and even global central banks are quietly fueling record demand for silver. This once-o...Goldco Precious Metals | SponsoredNew Buy Alert: Should you put $1,000 into Oracle (ORCL) now?Barron's is calling this Oracle's "Nvidia Moment..." While the Wall Street Journal is simply calling Oracle...Chaikin Analytics | SponsoredThis is the “End of Tesla” as we know it…Jeff has identified five of the past seven number-one performing tech stocks — before they took off. His Tesla...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding AirSculpt Technologies, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share AirSculpt Technologies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
